| Literature DB >> 36234953 |
Haibaier Huojiaaihemaiti1,2, Paiheerding Mutaillifu1,2, Adil Omer1,2, Rehebati Nuerxiati1, Xiaomei Duan1, Xuelei Xin1, Abulimiti Yili1.
Abstract
Elaeagnus angustifolia Linnaeus is a medicinal plant and its fruit has pharmacological activity such as antiinflammatory, antiedema, antinociceptive, and muscle relaxant functions, etc. Two acidic homogeneous polysaccharides (EAP-H-a1 and EAP-H-a2) were isolated from the fruits of Elaeagnus angustifolia L. through DEAE-52 and Sephadex G-75 column chromatography, and the physicochemical, structural properties, and biological activities of the polysaccharides were investigated. Both EAP-H-a1 and EAP-H-a2 were composed of Rha, Ara, Xyl, Glc, and Gal with the molar ratios of 13.7:20.5:23.3:8.8:33.4 and 24.8:19.7:8.2:8.4:38.6, respectively, and with the molecular weights of 705.796 kDa and 439.852 kDa, respectively. The results obtained from Fourier transform infrared spectroscopy (FTIR) confirmed the polysaccharide nature of the isolated substances. Congo red assay confirmed the existence of a triple-helix structure. Scanning electron microscopy (SEM) and X-ray diffraction (XRD) analysis revealed that EAP-H-a1 and EAP-H-a2 had irregular fibrous, filament-like surfaces; and both had crystalline and amorphous structures. Bioactivity analysis showed that the crude polysaccharide, EAP-H-a1, and EAP-H-a2 had clear DPPH and ABTS free radical scavenging activity, and could promote the secretion of NO and the phagocytic activities of RAW 264.7 and THP cells, which showed clear antioxidant and immuno-regulatory activity. These results indicated that Elaeagnus angustifolia L fruit acidic polysaccharides may have potential value in the pharmaceutical and functional food industries.Entities:
Keywords: acidic polysaccharides; antioxidant activity and immuno-regulatory; oleaster; structural elucidation
Mesh:
Substances:
Year: 2022 PMID: 36234953 PMCID: PMC9571751 DOI: 10.3390/molecules27196415
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Stepwise elution curves of the polysaccharide fractions using DEAE Sepharose-52 chromatography (A); Sephadex G-75 chromatography elution curve of different fractions (B,C).
Figure 2GC spectrum of the polysaccharides.
Monosaccharide composition and contents of the purified fractions.
| EAP-H-a1 | EAP-H-a2 | |
|---|---|---|
| Neutral sugar (%) | 12.55 | 12.24 |
| Protein (%) | 0 | 0 |
| Uronic acid (%) | 67.15 | 62.24 |
| Mw (kDa) | 705.79 | 439.85 |
| [α]20 D | +290.2 | +175.9 |
|
| ||
| Rha | 13.752 | 24.861 |
| Ara | 20.574 | 19.746 |
| Xyl | 23.361 | 8.282 |
| Glc | 8.894 | 8.474 |
| Gal | 33.418 | 38.637 |
Abbreviations: Rha, rhamnose; Ara, arabinose; Xyl, xylose; Man, mannose; Glc, glucose; Gal, galactose.
Figure 3IR spectrum of the polysaccharides.
Figure 4Congo red analysis of the polysaccharides.
Figure 5Scanning electron microscopy picture EAP-H-a2 (a–c); EAP-H-a1 (d–f).
Figure 6XRD spectrum of the EAP-H-a1 and EAP-H-a2.
Figure 7Thermal properties of EAP-H-a1 (A) and EAP-H-a2 (B).
Figure 81H (a)and 13C (b) spectra of EAP-H-a2.
Figure 9Antioxidant activity of the polysaccharides. (a) DPPH; (b) ABTS.
Figure 10Effects of different concentrations of polysaccharides on the cell viabilities on RAW 264.7 (a) and THP-1 (b); NO production on RAW 264.7 (c); phagocytic capacity on RAW 264.7 (d); and THP-1 (e).